Cardiotoxicity of the Anticancer Therapeutic Agent Bortezomib

Recent case reports provided alarming signals that treatment with bortezomib might be associated with cardiac events. In all reported cases, patients experiencing cardiac problems were previously or concomitantly treated with other chemotherapeutics including cardiotoxic anthracyclines. Therefore, i...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Nowis, Dominika, Mączewski, Michał, Mackiewicz, Urszula, Kujawa, Marek, Ratajska, Anna, Wieckowski, Mariusz R., Wilczyński, Grzegorz M., Malinowska, Monika, Bil, Jacek, Salwa, Paweł, Bugajski, Marek, Wójcik, Cezary, Siński, Maciej, Abramczyk, Piotr, Winiarska, Magdalena, Dąbrowska-Iwanicka, Anna, Duszyński, Jerzy, Jakóbisiak, Marek, Golab, Jakub
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society for Investigative Pathology 2010
Θέματα:
Regular Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2877829/
https://ncbi.nlm.nih.gov/pubmed/20519734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2010.090690
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια